(Eagle News) — The Philippine government has signed an agreement to secure 30 million doses of the COVID-19 vaccine Covovax from the Serum Institute of India. A statement from the SII’s local partner, Faberco Life Sciences Inc, said the vaccines will be available starting third quarter of this year. According to Faberco, SII partnered with Novavax, a US-based biotechnology company for the development and commercialization of the Covovax vaccine. Covovax is so far in third-stage […]